During the last session 1M of The Chemours Company’s (NYSE:CC) shares were traded. The stock closed at $33.54 per share indicating that it gained $0.29 or 0.87% during that day which brings the The Chemours Company’s valuation to $5.55B.
The 52-week high for the The Chemours Company’s shares is $38.87. That puts it -13.71% from that peak but still a 72.73% gain since the share price dropped to a 52-week low of $18.64, while the S&P 500’s share price change was of 33.41%.
The company currently has a 22.00 P/E ratio and a price target of $40.36.
What does the trading volume tell us about the CC stock?
During the last trading session, The Chemours Company (NYSE:CC) has seen growth in its daily volume. The daily volume was of 1M, while in the last 10 days the average was 994.53k and last three months – 1.21M.
The increasing interest in the CC stock from the investors is helping to drive the stock price up.
Shrinking short interest
The The Chemours Company’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 7.42M shares being shorted which translates into 5.85 of a short ratio for CC, while in the previous month the shorted shares were 7.64M.
The Chemours Company (NYSE:CC)’s financials
With a market cap of 5.55B, The Chemours Company holds a total cash of $1.14B that translates into $6.9 per share, while the total debt is of $4.23B.
The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 51.40%. The current revenue is of $5.66B that is $34.23 per share.
This is a great sign for a bright future.